New York Benicar Lawyers

Our New York Lawyers are Taking Cases for Patients Who Suffered an Injury or Illness While Taking Benicar

In July of 2013, the FDA issued an updated label warning that the drug Benicar (the generic name is olmesartan medoxomil) could cause sprue-like enteropathy; a disease often characterized by celiac-like symptoms which can damage the small intestine’s ability to absorb nutrients. The consequences of sprue-like enteropathy can be devastating, ranging from chronic diarrhea, dehydration, weight loss, and kidney failure to permanent intestinal damage. At Queller, Fisher, Washor, Fuchs & Kool, our New York Benicar lawyers are currently interviewing patients in New York State and nationwide who suffered serious injury or illness from taking the drug to help determine their legal options. We understand the hardships caused by Benicar-related injuries and illnesses and are determined to help victims recover compensation for their losses.

While our firm is located in lower-Manhattan, we do not restrict the cases we take to New York City. At Queller, Fisher, Washor, Fuchs & Kool, we understand the hardships that some patients with hypertension have been forced to endure after choosing Benicar to treat their high blood pressure. As a result we are committed to helping as many people who suffered unnecessary gastrointestinal problems as possible. We are currently evaluating cases from all over New York, including Manhattan, Queens, Brooklyn, Staten Island, the Bronx, Albany, Long Island, and all of up-state New York.

Our firm is also evaluating cases nationwide, as long as the statute of limitations for bringing a case has not expired in your particular state.

If you or someone you love has suffered from sprue-like enteropathy or another gastrointestinal illness while taking Benicar, you may have grounds to recover compensation from Daiichi Sankyo. For a free review of your legal options with our New York Benicar Attorneys, give us a call at 212-406-1700 or contact us on-line.